
The zzso system is an important treatment target towards improving both zzso zzso body zzso and zzso zzso body zzso zzso zzso can be achieved by increasing zzso zzso and/or insulin activity, which is dependent upon peripheral zzso production, transport across the zzso barrier zzso relevant to zzso zzso and effects upon zzso target zzso zzso zzso may also be achieved through zzso inverse zzso of zzso receptors (such as zzso of zzso zzso and directly through selective zzso zzso zzso such as zzso zzso zzso zzso zzso and zzso zzso While the development of most (but not all) zzso Y zzso as zzso interventions have demonstrated limited efficacy thus far, it is possible that the combination of a zzso Y inhibitor with a selective zzso zzso zzso may provide improved weight loss over that of either agent zzso In general, zzso system zzso promotes weight loss through decreasing zzso increasing sympathetic nervous system activity, and modulating zzso hormone, zzso hormone, zzso zzso factor, zzso hormone and zzso Of particular interest, given the development of zzso zzso zzso as weight loss agents, is the fact that receptors in the zzso system are also affected by the zzso zzso It will only be through the conduct of human clinical trials that zzso zzso will be proven to reduce zzso to a meaningful degree, and, as importantly, be proven to improve zzso and thus effectively treat excessive zzso zzso zzso 

